Drug Target Review2025-01-24T08:00:01
UVA researchers found that continuous glucose monitor data can predict nerve, eye, and kidney damage in type 1 diabetes.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-07-31T06:00:00Z
Contributor Dr Davinder Ramsingh, Drug Target Review
2023-01-20T14:24:55
Sponsored by Leica Microsystems
2026-06-29T06:49:00
Contributor Laura Alvarez, Drug Target Review
2026-09-30T13:00:00
Sponsored by Sartorius
2025-11-19T16:00:00
Sponsored by Eurofins DiscoverX
2025-10-08T14:00:00
Sponsored by Eurofins Discovery
2023-03-30T09:15:30
Sponsored by Halo Labs
Site powered by Webvision Cloud